Nearly €10M Invested in Quantum Innovations for Industry-Leading Surgical Sensor Tech

The technologies developed by Quantum Innovations have the potential to significantly improve outcomes in cardiothoracic surgeries. The ability to monitor the heart and other organs in real-time during surgery allows for greater precision and timely interventions, reducing the likelihood of complications. This continuous monitoring is crucial for maintaining the stability of the patient's condition and ensuring the success of the surgery.

Cardiothoracic surgeries are inherently high-risk procedures due to the complex nature of the organs involved and the critical need for precise interventions. Quantum Innovations’ Heart Sense and Heart Guard technologies offer a groundbreaking approach to these surgeries by providing surgeons with real-time data and insights that were previously unavailable. This can lead to better surgical outcomes, fewer post-operative complications, and lower mortality rates.

The Heart Sense technology is particularly revolutionary in its approach to real-time ECG monitoring. Traditional ECG monitoring involves leads placed on the patient's skin, which can provide valuable but limited information about the heart's electrical activity. However, the Heart Sense system goes a step further by allowing ECG monitoring directly from the surface of the beating heart. This direct approach offers a much clearer and more immediate picture of the heart’s condition during surgery, enabling surgeons to respond more effectively to any issues that arise.

By continuously monitoring the heart’s electrical activity, Heart Sense can help detect arrhythmias and other abnormalities as they occur, allowing for immediate corrective actions. This is especially important in complex cardiothoracic surgeries where even minor deviations in heart function can have significant consequences. The ability to monitor the heart so closely enhances the surgeon's ability to perform delicate procedures with greater confidence and precision.

Heart Guard technology complements the capabilities of Heart Sense by focusing on the metabolic state of the heart tissue. During cardiothoracic surgeries, there are often periods when the heart must be temporarily stopped. During these periods, ensuring the metabolic health of the heart tissue is crucial to prevent damage and ensure successful recovery post-surgery. Heart Guard tracks tissue metabolism in real-time, providing critical data about the tissue’s viability and health.

This technology is particularly valuable for surgeries involving prolonged periods of cardiac arrest, where maintaining tissue health is paramount. By monitoring metabolic markers, Heart Guard helps surgeons make informed decisions about the duration of cardiac arrest and the necessary interventions to preserve tissue integrity. This can reduce the risk of tissue damage and improve the overall outcomes of cardiac surgeries.

The nearly €10 million raised in Quantum Innovations’ second funding round will be instrumental in advancing these technologies. This funding will support further development, clinical trials, and the eventual commercialization of Heart Sense and Heart Guard. The successful deployment of these technologies in clinical settings will mark a significant advancement in cardiothoracic surgery and organ transplantation.

Grzegorz Suwalski, M.D., PhD, and his team at Quantum Innovations are poised to lead the way in transforming how surgeries are conducted, particularly those involving the heart. Their innovative solutions not only promise to enhance surgical precision and outcomes but also to set new standards in patient care and safety.

Quantum Innovations is at the forefront of medical technology with its pioneering sensor technologies, Heart Sense and Heart Guard. These innovations address critical gaps in current surgical practices, offering real-time monitoring and data-driven insights that significantly enhance the precision and success of cardiothoracic surgeries. The recent €10 million funding round will enable the company to advance these technologies, bringing them closer to widespread clinical use.

By providing continuous ECG monitoring directly from the heart’s surface and tracking tissue metabolism during critical periods, Quantum Innovations is set to revolutionize the field of cardiac surgery. These technologies promise to reduce complications, improve patient outcomes, and ultimately save lives. As Quantum Innovations continues to develop and refine its solutions, it stands to make a profound impact on the healthcare industry, offering new hope and improved care for patients undergoing complex surgeries.